126 related articles for article (PubMed ID: 7650070)
1. Pharmacokinetic comparison of oral and local action transcutaneous flurbiprofen in healthy volunteers.
Taburet AM; Singlas E; Glass RC; Thomas F; Leutenegger E
J Clin Pharm Ther; 1995 Apr; 20(2):101-7. PubMed ID: 7650070
[TBL] [Abstract][Full Text] [Related]
2. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
Ahmad M; Pervaiz F
Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and bioequivalence comparison between orally disintegrating and conventional tablet formulations of flurbiprofen: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male volunteers.
Liu YM; Liu GY; Liu Y; Li SJ; Jia JY; Zhang MQ; Lu C; Zhang YM; Li XN; Yu C
Clin Ther; 2009 Aug; 31(8):1787-95. PubMed ID: 19808137
[TBL] [Abstract][Full Text] [Related]
4. Plasma pharmacokinetics and synovial concentrations of S-flurbiprofen plaster in humans.
Yataba I; Otsuka N; Matsushita I; Kamezawa M; Yamada I; Sasaki S; Uebaba K; Matsumoto H; Hoshino Y
Eur J Clin Pharmacol; 2016 Jan; 72(1):53-9. PubMed ID: 26438533
[TBL] [Abstract][Full Text] [Related]
5. Clinical study on the bioequivalence of two tablet formulations of flurbiprofen.
Ozbay L; Unal DO; Cakici I; Fenercioglu A; Erol D
Eur J Drug Metab Pharmacokinet; 2009; 34(1):1-5. PubMed ID: 19462921
[TBL] [Abstract][Full Text] [Related]
6. A randomised, two-period, cross-over, open-label study to evaluate the pharmacokinetic profiles of single doses of two different flurbiprofen 8.75-mg lozenges in healthy volunteers.
Matzneller P; Burian A; Martin W; Annoni O; Lauro V; Tacchi R; Brunner M; Zeitlinger M
Pharmacology; 2012; 89(3-4):188-91. PubMed ID: 22433300
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of a topical NSAID patch (local action transcutaneous flurbiprofen) and oral diclofenac in the treatment of soft-tissue rheumatism.
Martens M
Clin Rheumatol; 1997 Jan; 16(1):25-31. PubMed ID: 9132322
[TBL] [Abstract][Full Text] [Related]
8. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations.
Pargal A; Kelkar MG; Nayak PJ
Biopharm Drug Dispos; 1996 Aug; 17(6):511-9. PubMed ID: 8866042
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability and pharmacokinetics of two oral formulations of flurbiprofen: a single-dose, randomized, open-label, two-period, crossover study in Pakistani subjects.
Qayyum A; Najmi MH; Abbas M
Pak J Pharm Sci; 2013 Nov; 26(6):1221-7. PubMed ID: 24191330
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of flurbiprofen in younger and elderly patients with rheumatoid arthritis.
Kean WF; Antal EJ; Grace EM; Cauvier H; Rischke J; Buchanan WW
J Clin Pharmacol; 1992 Jan; 32(1):41-8. PubMed ID: 1740536
[TBL] [Abstract][Full Text] [Related]
11. Single-dose pharmacokinetics of flurbiprofen granules and tablets in healthy volunteers.
Benvenuti C; Gambaro V; Lodi F; Scaroni C; Bandi G; Valenti M
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):334-7. PubMed ID: 2777421
[TBL] [Abstract][Full Text] [Related]
12. Nonlinear Pharmacokinetics of Topical Flurbiprofen Gel in a Phase I Study Among Chinese Healthy Adults.
Xiao W; Zhu Z; Xie F; Liu F; Cheng Z
Pharm Res; 2024 May; 41(5):911-920. PubMed ID: 38509321
[TBL] [Abstract][Full Text] [Related]
13. Effect of l-menthol-ethanol-water system on the systemic absorption of flurbiprofen after repeated topical applications in rabbits.
Morimoto Y; Hayashi T; Kawabata S; Seki T; Sugibayashi K
Biol Pharm Bull; 2000 Oct; 23(10):1254-7. PubMed ID: 11041263
[TBL] [Abstract][Full Text] [Related]
14. Flurbiprofen concentration in soft tissues is higher after topical application than after oral administration.
Kai S; Kondo E; Kawaguchi Y; Kitamura N; Yasuda K
Br J Clin Pharmacol; 2013 Mar; 75(3):799-804. PubMed ID: 22822928
[TBL] [Abstract][Full Text] [Related]
15. Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect.
Sonvico F; Conti C; Colombo G; Buttini F; Colombo P; Bettini R; Barchielli M; Leoni B; Loprete L; Rossi A
J Control Release; 2017 Sep; 262():296-304. PubMed ID: 28774840
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of systemic absorption and renal effects of topical ophthalmic flurbiprofen and diclofenac in healthy cats.
Lanuza R; Rankin AJ; KuKanich B; Meekins JM
Vet Ophthalmol; 2016 Jul; 19 Suppl 1():24-9. PubMed ID: 26119523
[TBL] [Abstract][Full Text] [Related]
17. Influence of the oral dissolution time on the absorption rate of locally administered solid formulations for oromucosal use: the flurbiprofen lozenges paradigm.
Imberti R; De Gregori S; Lisi L; Navarra P
Pharmacology; 2014; 94(3-4):143-7. PubMed ID: 25277061
[TBL] [Abstract][Full Text] [Related]
18. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
19. The effects and metabolic fate of nitroflurbiprofen in healthy volunteers.
Zacharowski P; Zacharowski K; Donnellan C; Johnston A; Vojnovic I; Forte P; Del Soldato P; Benjamin N; O'Byrne S
Clin Pharmacol Ther; 2004 Oct; 76(4):350-8. PubMed ID: 15470334
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers.
Geisslinger G; Lötsch J; Menzel S; Kobal G; Brune K
Br J Clin Pharmacol; 1994 Apr; 37(4):392-4. PubMed ID: 8018462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
